Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Protocols in Pharmacology|February 2, 2012
Electrocardiographic toxicity in the guinea pigPierre LacroixCurrent Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
QT interval prolongation and cardiac risk assessment for novel drugsSandra Picard, Pierre LacroixCurrent Protocols in Pharmacology|February 2, 2012
An overview of QT interval assessment in safety pharmacologyPierre Lacroix, Sandra PicardCurrent Protocols in Pharmacology|February 2, 2012
Gastrointestinal models: intestinal transit, gastric emptying, and ulcerogenic activity in the ratPhilippe Guillaume, Daniel Provost, Pierre LacroixCurrent Protocols in Pharmacology|February 2, 2012
Models of cardiovascular disease: measurement of arrhythmogenic/antiarrhythmic activity in the guinea pigPhilippe Guillaume, Daniel Provost, Pierre LacroixCurrent Protocols in Pharmacology|February 2, 2012
Cardiomyopathic Syrian hamster as a model of congestive heart failureSonia Goineau, Sandra Picard, Stéphane Hervé, et al.Current Protocols in Pharmacology|February 2, 2012
Orthostatic hypotension induced by postural change in the rat (tilt test)Philippe Guillaume, Stéphane Hervé, Sandra Picard, et al.European Journal of Pharmacology|September 27, 2003
Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac riskPierre Lacroix, William J Crumb, Lucia Durando, et al.Current Protocols in Pharmacology|February 2, 2012
Models of cardiovascular disease: measurement of antihypertensive activity in the conscious rat (SHR, DOCA-salt, and Goldblatt hypertension models)Philippe Guillaume, Daniel Provost, Pamela Legrand, et al.Journal of Pharmacological and Toxicological Methods|June 26, 2007
The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant riskNiklaus Dürmüller, Philippe Guillaume, Pierre Lacroix, et al.Pageof 2